A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Tsinghua Changgung Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Jiahong Dong, MD, PhD) · dongjiahong@mail.tsinghua.edu.cn · +86-10-56118899Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
The First Hospital of Jilin University, Changchun, Jilin, China